治療薬とバイオハイブリッド薬媒介としてのプロバイオティックバクテリア:進歩,設計戦略,将来の見通し
Deepsundar Sahoo1, Edgar Rodriguez1, Kytai Nguyen1
1Department of Bioengineering, University of Texas at Arlington, Arlington, Texas 76010, United States.
ACS applied bio materials
|September 1, 2025
まとめ
プロバイオティクスのバクテリアは 精密医療の 医薬品配達プラットフォームです 遺伝子工学とナノテクノロジーは,標的型療法,がん治療,ワクチン開発においてその使用を強化する.
科学分野:
- 微生物学
- ナノテクノロジー
- 生物医学工学
背景:
- プロバイオティクスのバクテリアは 標的型薬の投与のための バイオコンパティブルなプラットフォームを提供します
- ナノテクノロジーと遺伝子工学の進歩により 精密医療におけるプロバイオティクスの応用が拡大しています
- プロバイオティクスは治療薬,タンパク質,抗原,ナノ粒子 (NP) を提供することができます.
研究 の 目的:
- 薬媒介としてプロバイオティクスを使用する戦略を見直す.
- プロバイオティクスをナノ粒子ベースの配送システムに統合することに焦点を当てます.
- プロバイオティクスの機能強化のための遺伝子工学のアプローチを強調する.
主な方法:
- 細菌の幽霊,外膜膀 (OMV),表面膜タンパク質,および胞子などの多様なプロバイオティックキャリア戦略の探索.
- 機能化,ターゲティング,バイオコンパティビリティを考慮して,プロバイオティクスとのナノ粒子統合の分析.
- 遺伝子工学技術 (プラズミドベースの発現,ゲノム統合) を検討し,プロバイオティクスの投与を改善する.
主要な成果:
- プロバイオティクスは標的療法,免疫調節,ナノ粒子媒介薬の投与のために設計することができます.
- ナノ粒子との統合は標的の効率と生物互換性を高めます
- 様々なプロバイオティクスを用いたシステムは,がん治療,ワクチン開発,胃腸疾患の潜在力を示しています.
結論:
- プロバイオティクスのバクテリアは 次世代の標的型薬の提供に 有望なプラットフォームです
- 合成生物学と バイオハイブリッドシステムのさらなる進歩により 治療効果が最適化されます
- プロバイオティクスの利用は 精密医療の応用に 大きな可能性を秘めています
関連する概念動画
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Biological Methods for Microbial Control
199
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
199
Prodrugs
2.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.8K
Biopharmaceutics and Pharmacokinetics: Overview
2.5K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.5K
Hybridoma Technology
15.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.3K
Inflammatory Bowel Disease IV: Pharmacological Management
185
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
185


